Literature DB >> 19616500

Predictive value of seizure ICD-9 codes for vaccine safety research.

Irene M Shui1, Ping Shi, M Maya Dutta-Linn, Eric S Weintraub, Simon J Hambidge, James D Nordin, Tracy A Lieu.   

Abstract

Post-licensure vaccine safety studies often monitor for seizures using automated screening of ICD-9 codes. This study assessed the positive predictive value (PPV) of ICD-9 codes used to identify seizure visits in children aged 6 weeks to 23 months who were enrolled in seven managed care organizations during January 2000 to December 2005. ICD-9 codes were used to identify visits for seizures in the 0-30-day period following receipt of a pneumococcal vaccine. Visits were stratified by setting of diagnosis (emergency department (ED), outpatient, and inpatient). Review of medical records confirmed whether the visit represented a true acute seizure event. 3233 visits for seizures were identified; 1024 were randomly selected for medical record review and 859 (84%) had records available. The PPV of ICD-9 codes was highest in the ED setting (97%), followed by the inpatient setting (64%). In the outpatient setting, computerized codes for seizures had very low PPV: 16% on days 1-30 following vaccination and 2% for visits on the same day of vaccination. An estimated 77% of true seizures identified were from the ED or inpatient settings. In conclusion, when using ICD-9 codes to identify seizure outcomes, restricting to the ED and inpatient settings of diagnosis may result in less biased preliminary analyses and more efficient vaccine safety studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616500     DOI: 10.1016/j.vaccine.2009.06.092

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Authors:  Sharon K Greene; Martin Kulldorff; Edwin M Lewis; Rong Li; Ruihua Yin; Eric S Weintraub; Bruce H Fireman; Tracy A Lieu; James D Nordin; Jason M Glanz; Roger Baxter; Steven J Jacobsen; Karen R Broder; Grace M Lee
Journal:  Am J Epidemiol       Date:  2009-12-04       Impact factor: 4.897

2.  The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.

Authors:  Matthew F Daley; Christina L Clarke; Jason M Glanz; Stanley Xu; Simon J Hambidge; James G Donahue; James D Nordin; Nicola P Klein; Steven J Jacobsen; Allison L Naleway; Michael L Jackson; Grace Lee; Jonathan Duffy; Eric Weintraub
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-11-17       Impact factor: 2.890

3.  Bias from outcome misclassification in immunization schedule safety research.

Authors:  Sophia R Newcomer; Martin Kulldorff; Stan Xu; Matthew F Daley; Bruce Fireman; Edwin Lewis; Jason M Glanz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-01-02       Impact factor: 2.890

4.  Rotavirus Vaccination Is Associated With Reduced Seizure Hospitalization Risk Among Commercially Insured US Children.

Authors:  Rachel M Burke; Jacqueline E Tate; Rebecca Moritz Dahl; Negar Aliabadi; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

5.  Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event.

Authors:  Shirley V Wang; Kristina Stefanini; Edwin Lewis; Sophia R Newcomer; Bruce Fireman; Matthew F Daley; Jason M Glanz; Jonathan Duffy; Eric Weintraub; Martin Kulldorff
Journal:  Drug Saf       Date:  2020-10       Impact factor: 5.606

6.  Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children.

Authors:  Daniel C Payne; James Baggs; Danielle M Zerr; Nicola P Klein; Katherine Yih; Jason Glanz; Aaron T Curns; Eric Weintraub; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2013-11-20       Impact factor: 9.079

7.  Use of Neuroimaging for Children With Seizure in General and Pediatric Emergency Departments.

Authors:  Sarah C Cavallaro; Michael C Monuteaux; Pradip P Chaudhari; Kenneth A Michelson
Journal:  J Emerg Med       Date:  2021-01-05       Impact factor: 1.484

8.  Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysis.

Authors:  Kumanan Wilson; Steven Hawken; Jeffrey C Kwong; Shelley Deeks; Natasha S Crowcroft; Carl Van Walraven; Beth K Potter; Pranesh Chakraborty; Jennifer Keelan; Michael Pluscauskas; Doug Manuel
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

9.  Sustaining Research Networks: the Twenty-Year Experience of the HMO Research Network.

Authors:  John F Steiner; Andrea R Paolino; Ella E Thompson; Eric B Larson
Journal:  EGEMS (Wash DC)       Date:  2014-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.